Ahmad SS, Kanukollu VM. Optic Atrophy. 2022 Jan. [QxMD MEDLINE Link]. [Full Text].
Lenaers G, Hamel CP, Delettre C, Amati-Bonneau P, Procaccio V, Bonneau D, et al. Dominant optic atrophy. Orphanet J Rare Dis. 2012 Jul 9. 7(1):46. [QxMD MEDLINE Link].
Nakaso K, Adachi Y, Fusayasu E, Doi K, Imamura K, Yasui K, et al. Leber's Hereditary Optic Neuropathy with Olivocerebellar Degeneration due to G11778A and T3394C Mutations in the Mitochondrial DNA. J Clin Neurol. 2012 Sep. 8(3):230-4. [QxMD MEDLINE Link]. [Full Text].
Tielsch JM, Javitt JC, Coleman A, et al. The prevalence of blindness and visual impairment among nursing home residents in Baltimore. N Engl J Med. 1995 May 4. 332(18):1205-9. [QxMD MEDLINE Link].
Munoz B, West SK, Rubin GS, et al. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol. 2000 Jun. 118(6):819-25. [QxMD MEDLINE Link].
Ornek K, Ornek N. Visual recovery from optic atrophy following acute optic neuropathy in the fellow eye. J Res Med Sci. 2012 Jun. 17 (6):582-3. [QxMD MEDLINE Link].
Bissell AJ, Yalcinbayir O, Akduman L. Bilateral geographic atrophy: spontaneous visual improvement after loss of vision in the fellow eye. Acta Ophthalmol Scand. 2005 Aug. 83 (4):514-5. [QxMD MEDLINE Link].
Alasil T, Wang K, Yu F, Field MG, Lee H, Baniasadi N, et al. Correlation of retinal nerve fiber layer thickness and visual fields in glaucoma: a broken stick model. Am J Ophthalmol. 2014 May. 157 (5):953-59. [QxMD MEDLINE Link].
Yaqoob Z, Wu J, Yang C. Spectral domain optical coherence tomography: a better OCT imaging strategy. Biotechniques. 2005 Dec. 39 (6 Suppl):S6-13. [QxMD MEDLINE Link].
Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, Pan YI, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006 Jun. 59 (6):963-9. [QxMD MEDLINE Link].
Larrea BA, Iztueta MG, Indart LM, Alday NM. Early axonal damage detection by ganglion cell complex analysis with optical coherence tomography in nonarteritic anterior ischaemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2014 Nov. 252 (11):1839-46. [QxMD MEDLINE Link].
Savini G, Barboni P, Valentino ML, Montagna P, Cortelli P, De Negri AM, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations. Ophthalmology. 2005 Jan. 112 (1):127-31. [QxMD MEDLINE Link].
Gueven N. Idebenone for Leber's hereditary optic neuropathy. Drugs Today (Barc). 2016. 52(3):173-81. [QxMD MEDLINE Link]. [Full Text].
Klopstock T, Yu-Wai-Man P, Dimitriadis K, et al. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy. Brain. 2011 Sep. 134:2677-86. [QxMD MEDLINE Link]. [Full Text].
Lopez Sanchez MI, Crowston JG, Mackey DA, Trounce IA. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies. Pharmacol Ther. 2016. Sep 165:132-52. [QxMD MEDLINE Link]. [Full Text].
de Lima S, Koriyama Y, Kurimoto T, Oliveira JT, et al. Full-length axon regeneration in the adult mouse optic nerve and partial recovery of simple visual behaviors. Proc Natl Acad Sci U S A. 2012 Jun 5. 109(23):9149-54. [QxMD MEDLINE Link]. [Full Text].
Keirstead SA, Rasminsky M, Fukuda Y, Carter DA, Aguayo AJ, Vidal-Sanz M. Electrophysiologic responses in hamster superior colliculus evoked by regenerating retinal axons. Science. 1989 Oct 13. 246(4927):255-7. [QxMD MEDLINE Link].
Fischer D, Heiduschka P, Thanos S. Lens-injury-stimulated axonal regeneration throughout the optic pathway of adult rats. Exp Neurol. 2001 Dec. 172(2):257-72. [QxMD MEDLINE Link].
Vignal C, Uretsky S, Fitoussi S, Galy A, Blouin L, Girmens JF, et al. Safety of rAAV2/2-ND4 Gene Therapy for Leber Hereditary Optic Neuropathy. Ophthalmology. 2018 Jun. 125 (6):945-947. [QxMD MEDLINE Link].
Albert DM, Jakobeic FA. Optic atrophy. Principles and Practice of Ophthalmology. 2nd ed. Philadelphia: WB Saunders; 2000. 4108- 4113.
Anderson DR. Ascending and descending optic atrophy produced experimentally in squirrel monkeys. Am J Ophthalmol. 1973 Nov. 76(5):693-711. [QxMD MEDLINE Link].
Glaser JS. Neuro-Ophthalmology. 2nd ed. Philadelphia: JB Lippincott; 1990. 115-117.
Hoyt WF, Schlicke B, Eckelhoff RJ. Fundoscopic appearance of a nerve-fibre-bundle defect. Br J Ophthalmol. 1972 Aug. 56(8):577-83. [QxMD MEDLINE Link].
Kline LB, Bajandas FJ. Neuro-ophthalmology Review Manual. 5th ed. New Jersey: Slack; 2004. 153-164.
Kline LB, ed. Optic nerve disorders. Ophthalmology Monographs. San Francisco, Calif: American Academy of Ophthalmology; 1996. Vol 10:
Kuppersmith MJ, Krohn D. Cupping of the optic disc with compressive lesions of the anterior visual pathway. Ann Ophthalmol. 1984. 16:948-953.
Miller NR, Newman NJ. Walsh & Hoyt's Clinical Neuro-ophthalmology. 6th ed. Philadelphia: JB Lippincott; 208- 218.
Miller NR, Newman SA. Transsynaptic degeneration. Arch Ophthalmol. 1981 Sep. 99(9):1654. [QxMD MEDLINE Link].
Newman NJ. Optic disc pallor: a false localizing sign. Surv Ophthalmol. 1993 Jan-Feb. 37(4):273-82. [QxMD MEDLINE Link].
Patel DA, Hove MW. Focal Points. No 2. San Francisco, Calif: American Academy of Ophthalmology; March 2006. Vol XXIV:
Tasman W, Jaeger EA. Topical diagnosis of optic nerve lesions. Duane's Ophthalmology. Philadelphia: JB Lippincott; 2007.
Liao C, Ashley N, Diot A,et al. Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations. Neurology. 2017 Jan 10. 88 (2):131-142. [QxMD MEDLINE Link]. [Full Text].
Boegel KH, Tyan AE, Iyer VR, Rykken JB, McKinney AM. Utility of coronal contrast-enhanced fat-suppressed FLAIR in the evaluation of optic neuropathy and atrophy. Eur J Radiol Open. 2017. 4:13-18. [QxMD MEDLINE Link]. [Full Text].
Bourne SC, Townsend KN, Shyr C, Matthews A, Lear SA, Attariwala R, et al. Optic atrophy, cataracts, lipodystrophy/lipoatrophy, and peripheral neuropathy caused by a de novo OPA3 mutation. Cold Spring Harb Mol Case Stud. 2017 Jan. 3 (1):a001156. [QxMD MEDLINE Link]. [Full Text].
Varela-Fernández R, Lema-Gesto MI, González-Barcia M, Otero-Espinar FJ. Design, development, and characterization of an idebenone-loaded poly-ε-caprolactone intravitreal implant as a new therapeutic approach for LHON treatment. Eur J Pharm Biopharm. 2021 Nov. 168:195-207. [QxMD MEDLINE Link].
Vignal-Clermont C, Girmens JF, Audo I, Said SM, Errera MH, Plaine L, et al. Safety of Intravitreal Gene Therapy for Treatment of Subjects with Leber Hereditary Optic Neuropathy due to Mutations in the Mitochondrial ND4 Gene: The REVEAL Study. BioDrugs. 2021 Mar. 35 (2):201-214. [QxMD MEDLINE Link].